In this regard, a dysregulated signature of CD31+ endothelial-derived EVs could predict chronic HF phenotypes, improving conventional HF markers [24] and assess the risk of three-year cumulative cardiovascular events [25]. This evidence concerns the gene PECAM1 and hydrops fetalis.